Maryland is making big strides as a national leader in medical technology innovation, and the Robert E. Fischell Institute for Biomedical Devices, University of Maryland is at the forefront of this movement. By bringing together scientists, engineers, and industry leaders, the Institute drives innovation across prototyping, manufacturing, venture creation, and navigating clinical, regulatory, and reimbursement pathways.
Join us for a lively What’s the Buzz?! discussion on how the Fischell Institute and its work across the broader BioHealth Capital Region are shaping the future of healthcare.
We’re excited to welcome Martha Wang, Ph.D., Assistant Director of the Fischell Institute, who will explore:
– How the Fischell Institute is uniquely positioned to support the full medtech development journey—from concept to commercialization
– Key trends in medtech innovation and growth within the region
– Maryland Medtech Week and how collaboration is fueling the next wave of healthcare advancements
𝗔𝗯𝗼𝘂𝘁 𝗠𝗮𝗿𝘁𝗵𝗮 𝗪𝗮𝗻𝗴, 𝗣𝗵.𝗗.
Martha Wang is the Assistant Director at the Robert E. Fischell Institute for Biomedical Devices. With a strong background in FDA-compliant manufacturing and medical device development, she has successfully led teams in bringing innovative technologies from ideation to commercialization. Concurrently, she teaches at the Fischell Department of Bioengineering, University of Maryland. Previously, she held roles at Osiris Therapeutics, L’Oréal, and founded JWE, LLC for biotech consulting.
Martha’s expertise spans cGMP, cGTP, GLP, ICH compliance, process improvement, 3D printing, and manufacturing scale-up. She holds a Ph.D. from the Fischell Department of Bioengineering.
